Allopregnanolone Regenerative Therapeutic for Mild Alzheimer's Disease

This study is testing a drug called allopregnanolone — a naturally occurring brain hormone — to see if it can slow memory decline and support brain cell regeneration in people with mild Alzheimer's disease. **You may be eligible if:** - You are a man or a postmenopausal woman between 55 and 80 years old - You have been diagnosed with probable Alzheimer's disease based on recognized medical criteria - You have mild memory impairment (a score of 20–26 on a standard memory test) - A blood test shows a positive marker associated with Alzheimer's (p-Tau217) - You have the mental capacity to consent to the study **You may NOT be eligible if:** - Your memory problems are caused by something other than Alzheimer's disease - You take medications such as benzodiazepines, antipsychotics, or anticonvulsants - You have a history of stroke, seizures, brain injury, or significant brain abnormalities on MRI - You have had cancer in the past 5 years - You have serious heart, kidney, or liver disease Talk to your doctor to see if this trial is right for you.